Serum magnesium, ambulatory blood pressure, and carotid artery alteration: The ohasama study

American Journal of Hypertension

Volumn 23, Issue 12, 2010, Pages 1292-1298

  Hashimoto, Takanao ^a   Hara, Azusa ^a   Ohkubo, Takayoshi ^a   Kikuya, Masahiro ^a   Shintani, Yoriko ^a   Metoki, Hirohito ^a   Inoue, Ryusuke ^a   Asayama, Kei ^a   Kanno, Atsuhiro ^a   Nakashita, Manami ^a   Terata, Shiho ^a   Obara, Taku ^a,b   Hirose, Takuo ^a   Hoshi, Haruhisa ^c   Totsune, Kazuhito ^a,d   Satoh, Hiroshi ^a   Imai, Yutaka ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c Ohasama Ounty Medical Center   (Japan)

^d TOHOKU FUKUSHI UNIVERSITY   (Japan)

Author keywords

ambulatory blood pressure; blood pressure; carotid plaque; general population; hypertension; intima media thickness; serum magnesium

Indexed keywords

ANTIHYPERTENSIVE AGENT; CALCIUM; CREATININE; MAGNESIUM; PHOSPHATE; POTASSIUM; SODIUM;

ADULT; AGED; ANALYSIS OF COVARIANCE; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE MONITORING; CALCIUM BLOOD LEVEL; CAROTID ATHEROSCLEROSIS; CLINICAL EVALUATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HUMAN; INCIDENCE; JAPANESE; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PHOSPHATE BLOOD LEVEL; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CAROTID ARTERY DISEASE; CROSS-SECTIONAL STUDY; ECHOGRAPHY; INTIMA; MIDDLE AGED; PATHOLOGY;

AGED; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MAGNESIUM; MALE; MIDDLE AGED; TUNICA INTIMA;

EID: 79952276489     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2010.168     Document Type: Article

References (36)

1. Weglicki WB, Phillips TM. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am J Physiol 1992; 263:R734-R737.
2. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993; 21:1024-1029. (Pubitemid 23166961)
3. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 1995; 48:927-940.
4. Peacock JM, Folsom AR, Arnett DK, Eckfeldt JH, Szklo M. Relationship of serum and dietary magnesium to incident hypertension: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Epidemiol 1999; 9:159-165. (Pubitemid 29144455)
5. Ohira T. Psychological distress and cardiovascular disease: the Circulatory Risk in Communities Study (CIRCS). J Epidemiol 2010; 20:185-191.
6. Champagne CM. Magnesium in hypertension, cardiovascular disease, metabolic syndrome, and other conditions: a review. Nutr Clin Pract 2008; 23:142-151. (Pubitemid 351508219)
7. Akizawa Y, Koizumi S, Itokawa Y, Ojima T, Nakamura Y, Tamura T, Kusaka Y. Daily magnesium intake and serum magnesium concentration among Japanese people. J Epidemiol 2008; 18:151-159.
8. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991; 229:225-231.
9. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 20:159-169. (Pubitemid 34913777)
10. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotidartery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340:14-22. (Pubitemid 29024679)
11. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intimamedia thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96:1432-1437. (Pubitemid 27375333)
12. Ohkubo T. Prognostic significance of variability in ambulatory and home blood pressure from the Ohasama study. J Epidemiol 2007; 17:109-113.
13. Shintani Y, Kikuya M, Hara A, Ohkubo T, Metoki H, Asayama K, Inoue R, Obara T, Aono Y, Hashimoto T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory blood pressure, blood pressure variability and the prevalence of carotid artery alteration: the Ohasama study. J Hypertens 2007; 25:1704-1710. (Pubitemid 47056579)
14. Imai Y, Nagai K, Sakuma M, Sakuma H, Nakatsuka H, Satoh H, Minami N, Munakata M, Hashimoto J, Yamagishi T. Ambulatory blood pressure of adults in Ohasama, Japan. Hypertension 1993; 22:900-912. (Pubitemid 23358099)
15. Hara A, Ohkubo T, Kikuya M, Shintani Y, Obara T, Metoki H, Inoue R, Asayama K, Hashimoto T, Harasawa T, Aono Y, Otani H, Tanaka K, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Detection of carotid atherosclerosis in individuals with masked hypertension and white-coat hypertension by self-measured blood pressure at home: the Ohasama study. J Hypertens 2007; 25:321-327. (Pubitemid 46071930)
16. Bonithon-Kopp C, Touboul PJ, Berr C, Leroux C, Mainard F, Courbon D, Ducimetie P. Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study. Arterioscler Thromb Vasc Biol 1996; 16:310-316. (Pubitemid 26056252)
17. Imai Y, Nihei M, Abe K, Sasaki S, Minami N, Munakata M, Yumita S, Onoda Y, Sekino H, Yamakoshi K. A finger volume-oscillometric device for monitoring ambulatory blood pressure: laboratory and clinical evaluations. Clin Exp Hypertens A 1987; 9:2001-2025. (Pubitemid 18057382)
18. White WB, Anwar YA. Evaluation of the overall efficacy of the Omron office digital blood pressure HEM-907 monitor in adults. Blood Press Monit 2001; 6:107-110. (Pubitemid 32587668)
19. American National Standards for Electronic or Automated Sphygmomanometers. AAMI Analysis and Review: Washington, DC, 1987.
20. Kikuya M, Hansen TW, Thijs L, Bjklund-Bodegd K, Kuznetsova T, Ohkubo T, Richart T, Torp-Pedersen C, Lind L, Ibsen H, Imai Y, Staessen JA. Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Circulation 2007; 115:2145-2152. (Pubitemid 46659066)
21. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
22. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989; 5:303-311; discussion 312-303.
23. Apple F, Bandt C, Prosch A, Erlandson G, Holmstrom V, Scholen J, Googins M. Creatinine clearance: enzymatic vs Jaff?determinations of creatinine in plasma and urine. Clin Chem 1986; 32:388-390. (Pubitemid 17025671)
24. Horio M, Orita Y. Comparison of Jaffrate assay and enzymatic method for the measurement of creatinine clearance. Nippon Jinzo Gakkai Shi 1996; 38: 296-299. (Pubitemid 126496396)
25. Booth JV, Phillips-Bute B, McCants CB, Podgoreanu MV, Smith PK, Mathew JP, Newman MF. Low serum magnesium level predicts major adverse cardiac events after coronary artery bypass graft surgery. Am Heart J 2003; 145:1108-1113. (Pubitemid 36688265)
26. Amighi J, Sabeti S, Schlager O, Mlekusch W, Exner M, Lalouschek W, Ahmadi R, Minar E, Schillinger M. Low serum magnesium predicts neurological events in patients with advanced atherosclerosis. Stroke 2004; 35:22-27. (Pubitemid 38057583)
27. Atabek ME, Kurtoglu S, Pirgon O, Baykara M. Serum magnesium concentrations in type 1 diabetic patients: relation to early atherosclerosis. Diabetes Res Clin Pract 2006; 72:42-47.
28. Randell EW, Mathews M, Gadag V, Zhang H, Sun G. Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis 2008; 196:413-419.
29. Ohkubo T, Hozawa A, Nagai K, Kikuya M, Tsuji I, Ito S, Satoh H, Hisamichi S, Imai Y. Prediction of stroke by ambulatory blood pressure monitoring versus screening blood pressure measurements in a general population: the Ohasama study. J Hypertens 2000; 18:847-854. (Pubitemid 30459485)
30. Ohkubo T, Kikuya M, Metoki H, Asayama K, Obara T, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. J Am Coll Cardiol 2005; 46:508-515. (Pubitemid 41040294)
31. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S, Hashimoto J, Totsune K, Hoshi H, Satoh H, Imai Y. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45:240-245. (Pubitemid 40179967)
32. Morrill GA, Gupta RK, Kostellow AB, Ma GY, Zhang A, Altura BT, Altura BM. Mg2+ modulates membrane lipids in vascular smooth muscle: a link to atherogenesis. FEBS Lett 1997; 408:191-194. (Pubitemid 27226794)
33. Maier JA, Malpuech-Bruge C, Zimowska W, Rayssiguier Y, Mazur A. Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim Biophys Acta 2004; 1689:13-21. (Pubitemid 38670498)
34. Adhikari S, Toretsky JA, Yuan L, Roy R. Magnesium, essential for base excision repair enzymes, inhibits substrate binding of N-methylpurine-DNA glycosylase. J Biol Chem 2006; 281:29525-29532. (Pubitemid 44536960)
35. Ohira T, Peacock JM, Iso H, Chambless LE, Rosamond WD, Folsom AR. Serum and dietary magnesium and risk of ischemic stroke: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2009; 169:1437-1444.
36. Chambers EC, Heshka S, Gallagher D, Wang J, Pi-Sunyer FX, Pierson RN Jr. Serum magnesium and type-2 diabetes in African Americans and Hispanics: a New York cohort. J Am Coll Nutr 2006; 25:509-513. (Pubitemid 46175666)